crossover randomized trial

S003146

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

Other conditionsS003146

Design

Randomized: 10
Start year
Treatment: 0.02 weeks
Countries: Sweden (1 sites)
Sponsor: (not reported)
Eligibility: age 18 to 60; no diabetes; 1 year after gastric bypass; 40 to 80 percent excess weight loss

Conduct and analysis

Blinding: not reported
Sequence generation: not reported
Allocation concealment: not reported
Outcome adjudication: not reported
Primary estimand: not stated
Analysis population
Missing data

Arms

Arm	Treatment	Background	Randomized	Analyzed	Completed treatment
A1	Placebo Saline infusion	lifestyle: not reported	10	10
A2	exenatide Exenatide infusion	lifestyle: not reported	10	10

Baseline characteristics

As printed in the trial reports or registry, per arm or for the whole trial.

Characteristic	Statistic	Whole trial ALL
age	median (years)	42
bmi	median (kg/m2)	30.9
female	n	9
hba1c	median (mmol/mol)	33.3
sbp	median (mmHg)	122
waist	median (cm)	94.5
weight	median (kg)	80.7